Switzerland· 55345008

Cellufluid

A künstliche tränenflüssigkeit und sonstige indifferente präparate product containing carmellosum natricum, registered in Switzerland and dispensed under Swissmedic category D, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat D (Swissmedic)ATC S01XA20

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedCellufluidATCS01XA20REGISTER NO.55345008PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Künstliche tränenflüssigkeit und sonstige indifferente präparate is registered in 11 of 19 countries.

Countries holding a registration under ATC S01XA20 (künstliche tränenflüssigkeit und sonstige indifferente präparate), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 7 of them publish a price we can compare per daily dose

Künstliche tränenflüssigkeit und sonstige indifferente präparate · ATC S01XA20

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Active substance
carmellosum natricum
Manufacturer
—
Country
Switzerland (CH)
ATC code
S01XA20
ATC class
Künstliche Tränenflüssigkeit und sonstige indifferente Präparate
Swissmedic category
D
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680553450083
    10 ml
    CHF 5.6

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Künstliche tränenflüssigkeit und sonstige indifferente präparate in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All künstliche tränenflüssigkeit und sonstige indifferente präparate products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Czechia · Cellufluid
  • Denmark · Celluvisc
  • Spain · Carmelosa Qualigen, Carmelosa Stada
  • Finland · Celluvisc
  • France · Celluvisc
  • United Kingdom (Northern Ireland) · Celluvisc
  • Greece · Refresh Plus
  • Ireland · Celluvisc
  • Italy · Celluvisc
  • Netherlands · Cellufluid, Celluvisc
  • Portugal · Celluvisc
  • Sweden · Cellufluid, Celluvisc
  • Slovakia · Cellufluid

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/96415e94-586e-47ea-a799-8936901e8e65
GET /v1/drugs/96415e94-586e-47ea-a799-8936901e8e65?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "carmellosum natricum 5 mg",
  "valid_from": "2003-04-01",
  "limitations": null,
  "galenic_form": "Gtt Opht",
  "therapeutic_area": null,
  "sl_inclusion_date": "2003-04-01",
  "self_retention_pct": 10
}

See everything about künstliche tränenflüssigkeit und sonstige indifferente präparate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.